Podcasts about Sensor

HT2426 - Sensor Clean X2 I cringe every time I see those fuzzy blue circles in the sky that indicate I have dust on the sensor of the camera. I was given a suggestion by a reader about one way to deal with this and used it religiously these last two months as I was out in the dusty West photographing. I'm delighted to report that I had not a single indication of any dust on any shot. Show your appreciation for our free weekly Podcast and our free daily Here's a Thought… with a donation Thanks!

Markus Sauer läuft 223 km über die Alpen – mit Typ-1-Diabetes! In dieser Folge erfährst du, wie er den Transalpine Run gemeistert hat, welche Rolle mentale Stärke und gutes Blutzuckermanagement spielen und warum der Weg über die Alpen manchmal mehr Kopfsache als Muskelkraft ist. Pure Motivation für alle Diabetiker (und Nicht-Diabetiker)! -- [Werbung]  Die Folge wird präsentiert von FreeStyle Libre Maßsystem – dem derzeit kleinsten und flachsten Sensor der Welt. Nach einer Aktivierungszeit von 60 Minuten misst der Sensor jede einzelne Minute. Weitere Infos und Hinweise zum FreeStyle Libre Messsystem: https://www.freestylelibre.de/produkte/freestyle-libre-3-entdecken.html [Werbung] Show Notes Weitere Infos zu FreeStyle Libre 3https://www.freestylelibre.de/produkte/freestyle-libre-3-entdecken.html www.freestylelibre.de Erwähnte Seiten, Blogs etc. https://www.uni-bayreuth.de/pressemitteilung/leitlinie-diabetes-sport https://www.suess-sauer.at/2025/09/22/blutzuckermanagement-beim-transalpine-run/ 230 – Markus Sauer – als Diabetiker 4 Marathons in 4 Wochen 344 – 9 Marathons in 9 Tagen – Der Tag danach Kontaktdaten https://www.instagram.com/sauermax/ https://www.suess-sauer.at/   Music by by Breakz Studios & Nick Valerson from Pixabay

In dieser Folge erfährst du, warum moderne Sensortechnik längst mehr als nur „Kuhüberwachung“ ist – Sie kann dich dabei unterstützt, Krankheiten früher zu erkennen und deine Arbeit im Stall effizienter zu gestalten. Christian spricht mit Alexander Stelljes, ehemaligem Herdenmanager bei Benninghoff Milchenergie (1.200 Kühe, 14.500 kg Milchleistung) und seit 2025 Teil des Teams von CowManager. Er erzählt, wie er als Quereinsteiger zum echten Kuhmenschen wurde – und was ihn an der digitalen Herdenüberwachung begeistert. Du erfährst,

Viele glauben, ihre Augen sind einfach „müde vom Schauen“.Aber was, wenn dein ständiger Blick auf den Bildschirm nicht nur die Augen, sondern dein ganzes Nervensystem unter Stress setzt – und damit auch deine Konzentration, Haltung und Leistungsfähigkeit beeinflusst?In diesem Interview mit Stefanie Hennigfeld von Dynamic Eye erfährst du:warum Bildschirmarbeit dein visuelles System dauerhaft überfordert – und wie sich das auf dein Gehirn auswirktwie visuelle Ermüdung zu Verspannungen, Kopfschmerzen und sogar Schmerzen in anderen Körperregionen führtwelche Signale dir zeigen, dass deine Augen gestresst sind (und du sie bisher übersehen hast)3 einfache Tests, mit denen du deine visuelle Belastung selbst überprüfen kannstund welche neurozentrierten Übungen sofort für mehr visuelle Klarheit, weniger Spannung und bessere Selbstregulation sorgenHighlights aus der Folge:„Deine Augen sind kein passiver Sensor – sie steuern, wie dein Gehirn den Raum, Bewegung und Sicherheit wahrnimmt.“„Wenn dein visuelles System unter Dauerstress steht, reagiert dein gesamtes Nervensystem wie bei einer unterschwelligen Bedrohung.“„Oft trainieren wir Muskeln – aber vergessen das wichtigste Steuerorgan: das Auge.“Neuro 360 ist der Podcast für Therapeuten, Trainer und gesundheitsbewusste Menschen, die mit Neuroathletik und neurozentriertem Training Schmerzen reduzieren, Bewegungsqualität verbessern und Leistung steigern wollen.Lisa und Andreas Könings geben in ihrem Neuro-Podcast praxiserprobtes, evidenzbasiertes Wissen rund um Nervensystem und Gehirn weiter – klar und einfach erklärt, damit du Neuro-Training direkt in Therapie, Training und Alltag umsetzen kannst.

Wie wechselt man ein Objektiv an einer Canon-Kamera richtig? Viele denken: „Einfach abdrehen, neues drauf, fertig.“Aber bei spiegellosen Kameras wie der Canon R5 oder R6 zum Beispiel, gibt es ein paar Dinge, die du wissen solltest – damit dein Sensor sauber bleibt und dein Bajonett auch nach Jahren noch präzise sitzt.Schritt für Schritt:➡️ Warum du die Kamera beim Wechsel ausschalten solltest➡️ Wie du im Menü den Verschlussvorhang aktivierst➡️ Wann du besser nicht wechselst (Stichwort Wind, Sand, Regen)➡️ Wie du Objektive sicher an- und absetzt➡️ Und worauf du beim Bajonett wirklich achten solltestEin sauberer Objektivwechsel schützt nicht nur dein Equipment, sondern spart dir auch Zeit bei der Nachbearbeitung. Denn jedes Staubkorn auf dem Sensor siehst du später im Bild – und das muss nicht sein.Mein Name ist André Leisner, gebürtiger Kieler und jetzt in Lübeck lebend. Mit meinem Podcast möchte ich Dir einen Einblick hinter die Kulissen eines Berufsfotografen geben und Dir nützliche Tipps zum Thema Fotografie an die Hand geben.Mehr über mich erfährst Du hierWebseite: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://photography-leisner.de⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠YouTube: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.youtube.com/@photographyleisner⁠⁠Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@photographyleisner⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/photographyleisner⁠⁠⁠⁠

Walmart plans to deploy 90 million Bluetooth sensors across its inventory by end of 2026 in partnership with Wiliot. The "pixels" work like GPS trackers on every item, dramatically enhancing supply chain efficiency and cold chain compliance. Currently in 500 locations, the technology will expand to 4,600 stores and 40+ distribution centers. Chris and Anne discuss how this solves real operational problems... from preventing listeria outbreaks to ensuring strawberries stay fresh... while providing unprecedented inventory visibility that could be crucial as AI shopping assistants reshape consumer behavior. #Walmart #Wiliot #SupplyChain #InventoryTracking #RetailTech #IoT #FoodSafety #BluetoothSensors #ColdChain #RetailInnovation

Most older adults want to age in place, but families and caregivers can't be there 24/7. wisdom.io uses edge computing + radar + computer vision to detect falls and anomalies without wearables—keeping data inside the home and only sending alerts. CEO Cathy Minter shares:• Market reality & unmet needs in home care• Tech stack, privacy, and why edge > cloud for seniors• B2B2C go-to-market (home-care agencies, hospital discharge, 55+ communities)• Pricing, unit economics, and pilot accuracy targets• Samsung partnership: Wisdom on the Go (outside-home safety & gait insights)• Competition (Sensi.AI, SafelyYou) and empathy-led designChapters:00:00 Intro & the aging-in-place gap03:23 Founder story & market stats05:45 Product overview (edge hub, sensors)06:04 Privacy & on-device AI08:33 Hardware/installation Q&A10:08 Sensor fusion & smart-home vision11:25 GTM & channels14:02 Pricing model17:14 Home-care market size18:27 Pilot design & accuracy20:00 Competitors & differentiation23:10 Scale strategy & Samsung26:42 Closing & investor notes

Se me estropeó un sensor SNZB-04 y cuando fui a comprar otro para cambiarlo me di cuenta de que ya no existe, y ahora Sonoff ofrece sólo la versión P actualizada. El cambio ha venido con una mejora inesperada.

#newproducts JP's Product Pick of the Week 10/14/25 AS5600 Magnetic Angle Sensor https://www.adafruit.com/product/6357 Visit the Adafruit shop online - http://www.adafruit.com ----------------------------------------- LIVE CHAT IS HERE! http://adafru.it/discord Subscribe to Adafruit on YouTube: http://adafru.it/subscribe New tutorials on the Adafruit Learning System: http://learn.adafruit.com/ -----------------------------------------

This week's EYE ON NPI will help you breathe easier, with the smallest CO2 sensor we've ever seen: it's the Sensirion STCC4 Miniature CO2 Sensor (https://www.digikey.com/en/product-highlight/s/sensirion/stcc4-miniature-co2-sensor) Sensirion has always been our top choice for air quality sensing, and now they've got the tiniest sensor yet with ambient-air CO2 measurements. We've covered many Sensirion CO2 sensors before, and made breakouts for the most popular like the SCD-30 (https://www.digikey.com/en/products/detail/sensirion-ag/SCD30/8445334) and SCD-40 (https://www.digikey.com/en/products/detail/sensirion-ag/SCD40-D-R2/13684003). Sensirion has also made fully-integrated sensors like the SEN-66 which have an SCD sensor inside (https://www.digikey.com/en/products/detail/sensirion-ag/SEN66-SIN-T/25700945). There's also older eCO2 sensors like the SGP30 (https://www.digikey.com/en/products/detail/sensirion-ag/SGP30-2-5K/7400966) which did 'effective' CO2 measurements by estimating based on organic gas concentrations. While CO2 measurements have always been important for keeping humans and animals happy (https://en.wikipedia.org/wiki/Carbon_dioxide#Human_physiology) - our bodies and brains don't like it when the CO2 concentration goes over ~2000 ppm - it was fairly uncommon to see CO2 monitors in homes or offices. That changed with Covid, because CO2 became a good stand-in for air circulation / clearance: outside air is around 400 ppm, so the closer the indoor air is to 400 ppm the better the circulation. For folks who need the most accurate CO2 sensing, we'd still point them to the SCD-30 NDIR as a gold-standard (https://www.digikey.com/en/products/detail/sensirion-ag/SCD30/8445334) but it has the side effect of requiring a lot of space and is not particularly low power. The SCD-40 improved on the size/power requirements, using acoustic sensing instead of infrared light. However, if you want something really small, for wearables or phones or portable sensing, we now have a new sensor! The Sensirion STCC4 Miniature CO2 Sensor (https://www.digikey.com/short/nn982w9w) is only 3mm x 4mm x 1.2mm and uses thermal conductivity of the ambient air to calculate CO2 concentration. This means it works only for 'natural ambient air' measurements that have a similar profile to outdoor/indoor air, it's not good for scientific measurement or extreme/outlier locations and situations. Like the SCD30 and '40 series, the STCC4 will auto-calibrate (https://www.digikey.com/short/nn982w9w) to account for drift. To do that, it must be exposed to outdoor air, with approximate 400 ppm CO2 concentration once a week. Once it has completed its initial startup calibration, it will give measurements with +-100ppm accuracy. Note that this is not as good as the SCD30's +-30ppm or the SCD40's +-50ppm as the tradeoff for the smaller size and price. It also works best with separate temperature + humidity calibration - they suggest the SHT4x series such as SHT40 (https://www.digikey.com/en/products/detail/sensirion-ag/SHT40-AD1B-R3/14322709) or SHT41 (https://www.digikey.com/en/products/detail/sensirion-ag/SHT41-AD1B-R3/15296592) which you can wire up to the peripheral I2C pins for automatic readings. We noted that although the specifications for the STCC4 imply you can use 5V power/logic, that doesn't apply to the SHT4x series so its better to just have everything run at 3.3V. Sensor readings happen over I2C, and if you've used other Sensirion products you're probably familiar with their 'Command / Response / CRC' style of messaging. Thankfully no clock stretching is used, although it will NAK if the message isn't handled during a read. Two I2C addresses are available thanks to an ADDR pin. And if you want to get started fast, there's a ready-written Arduino compatible library available on GitHub (https://github.com/Sensirion/arduino-i2c-stcc4) as well as Python and embedded C (https://github.com/Sensirion?q=stcc&type=all&language=&sort=). For fast plug-and-play integration, Sensirion has also released an eval board (https://www.digikey.com/short/qwn75j80) and we really like that they went with a simple low-cost Qwiic/Stemma QT design (https://learn.adafruit.com/introducing-adafruit-stemma-qt/what-is-stemma) with integrated SHT4x that you can use immediately with dev board that has a JST-SH compatible connector. If you want to integrate the smallest, lowest-cost CO2 sensor we've seen, from the experts at Sensirion, check out the Sensirion STCC4 Miniature CO2 Sensor (https://www.digikey.com/short/nn982w9w) - it's in stock right now for immediate shipment from DigiKey! Order the STCC4 sensor today and by tomorrow morning you'll be taking measurements of indoor CO2 with ready-to-go eval board and firmware example code.

GRACIAS POR ESCUCHAR ESTE PODCAST-En el episodio de hoy os hablos de unas de las ultimas compras realizadas ,casi todo tecnología.Son productos de poco importe que que funcionan muy bien para el dia a dia.ARTICULOS COMENTADOS EN EL PODCASTConmutador de red divisor de Internet de 1000Mbps, concentrador LAN RJ45, adaptador Ethernet estableRegleta de alimentación de 3 metros con 8 almohadillas y 3 USB + 1 USB C (2500W/10A), protección contra sobremarcha con interruptor independienteLuces Led nocturnas con Sensor táctil, ahorro de energía, recargable por USB, luz de pared magnética para habitación, pasillo, dormitorio, lámpara nocturna portátil redondapara más información puedes pasarte por cacharreogeek.comcontactohola@cacharreogeek.comgracias

Protect privacy and battery life with ST's fifth-generation Human Presence Detection (HPD). The technology is based on our VL53L8CP Time-of-Flight sensor and a machine learning algorithm capable of running on low-power microcontrollers.

In dieser Folge spreche ich mit Nadine Banten, die nach ihrer Zeit in der Diabetesklinik Bad Mergentheim ihr Leben mit Typ-1-Diabetes völlig neu entdeckt hat. Aus Angst wurde Selbstvertrauen, aus Kontrolle wurde Freiheit. Nadine erzählt, wie Schulungen, Verständnis und Humor ihr halfen, endlich wieder Lebensqualität zu spüren – und warum selbst ein Nutella-Brötchen zum Symbol für Mut werden kann.

Hallo ihr Lieben, heute habe ich eine ganz besondere Frau bei mir im BB RADIO Mitternachtstalk Podcast: Kathi Korn. Sie ist Health-Influencerin, Speakerin, Unternehmerin, Bestseller-Autorin und dreifache Mama. Aber vor allem ist sie eine Frau, die Mut macht. Eine, die zeigt, dass man auch mit chronischen Erkrankungen mitten im Leben stehen kann. Mit Anfang 20 bekam Kathi die Diagnose Typ-1-Diabetes. Damals war sie Leistungssportlerin im Tischtennis, Deutsche Meisterin, und trotzdem rieten ihr Ärztinnen und Ärzte, den Sport aufzugeben und besser keine Kinder zu bekommen. Das war natürlich ein Schock, und sie fiel erst einmal in ein tiefes Loch. Aber wer Kathi kennt, weiß: Aufgeben ist nicht ihr Ding. Sie kämpfte sich zurück, startete auf Social Media durch und begann, ihre Erfahrungen offen zu teilen. Heute klärt sie über Diabetes und Lipödem auf, kämpft gegen Vorurteile und zeigt, dass man selbst Expertin seiner eigenen Gesundheit sein kann. Ein wichtiger Fakt: In Deutschland leben aktuell rund 11 Millionen Menschen mit Diabetes, dazu kommt noch eine nicht unerhebliche Dunkelziffer. Kathi setzt sich dafür ein, diese Krankheit sichtbarer zu machen und Aufklärung zu betreiben. Und weil Kathi nicht nur über Mut spricht, sondern ihn lebt, stand sie 2024 sogar im Halbfinale von Miss Germany. Dort wollte sie zeigen, dass Schönheit und Stärke nichts mit Perfektion zu tun haben, sondern mit Authentizität, Haltung und Herz. Ihr Engagement geht aber noch weiter. Kathi ist Botschafterin der neuen Barbie mit Typ-1-Diabetes. Diese Puppe trägt Insulinpumpe und Sensor und hilft Kindern, den Umgang mit Diabetes spielerisch zu verstehen. Für Kathi und ihre Töchter ist das ein echter Meilenstein in Sachen Sichtbarkeit und Inklusion. In unserem Talk heute geht es um Mut, Technik, Ehrlichkeit und die Kunst, auch an schwierigen Tagen nicht die Zuversicht zu verlieren. Wie man Familie, Beruf und chronische Krankheiten unter einen Hut bringt und warum Aufgeben für sie nie eine Option war. Freut euch auf eine starke, inspirierende Frau, die mit ihrer Geschichte zeigt, dass Grenzen dazu da sind, um verschoben zu werden. Also macht es euch gemütlich und hört das tolle Gespräch mit Kathi Korn im BB RADIO Mitternachtstalk. Gast https://www.instagram.com/diabeteswelt_lipaktiv/?hl=de https://www.facebook.com/kathrin.schanz.14 https://www.youtube.com/@Diabeteswelt https://missgermany.com/teilnehmerin/kathi-korn/ Jens https://www.instagram.com/jensherrmannofficial/?hl=de https://www.facebook.com/jens.herrmann.792 https://www.youtube.com/@JensHerrmann BB RADIO https://www.bbradio.de/ https://www.bbradio.de/shows/51d91f74-b052-42f5-978f-988dd1807ed9 https://www.instagram.com/bbradioofficial/ https://www.facebook.com/bbradioofficial https://www.tiktok.com/search?q=bb%20radio%20offiziell&t=1754913599724

#newproducts JP's Product Pick of the Week 10/7/25 OPT4048 Tristumulus XYZ Color Sensor https://www.adafruit.com/product/6335 Visit the Adafruit shop online - http://www.adafruit.com ----------------------------------------- LIVE CHAT IS HERE! http://adafru.it/discord Subscribe to Adafruit on YouTube: http://adafru.it/subscribe New tutorials on the Adafruit Learning System: http://learn.adafruit.com/ -----------------------------------------

Nachdem sich der initiale Text mit infrastrukturellen Hintergründen aktueller Satellitennetzwerke befasste, beleuchtet das vorliegende Addendum anhand eines Projektes wie »Climate Trace« Anwendungsmöglichkeiten beim Konsumenten. Denn genau dessen Emissionsdaten stehen nun im Mittelpunkt – und werden ihn langfristig Wohlstand und Bewegungsfreiheit kosten.Ein Standpunkt von Tom-Oliver Regenauer.Während die Gehirnwindungen unserer Spezies vom zerebral-sedativen Komplex – den Medien – mit Migration, Aufrüstungsrhetorik und Plattformplattitüden im permanenten Ausnahmezustand gehalten werden und viele Zeitgenossen dem Trugschluss aufzusitzen scheinen, der Nachhaltigkeitskorporatismus hätte ob der konservativ angehauchten Politrochaden der letzten Monate den Rückwärtsgang eingelegt, nimmt jene Infrastruktur, die uns sehr bald unsere Individualmobilität, ja unsere Freiheit kosten wird, fernab der auf Bildschirme glotzenden Öffentlichkeit immer konkretere Formen an. Die meisten werden das Geofencing-Gefängnis trotz all der Warnungen aber wohl erst dann erkennen, wenn seine unsichtbaren Gitterstäbe sie am Reisen, Einkaufen oder anonymen Surfen hindern.Die zwei Schlüsselelemente für die postmoderne Tyrannei der Marke Biofeudalismus: die digitale Identität (eID) mit ihrem umfassenden Potenzial zum Mikromanagement des Individuums – und ein lückenloses Netz von Satelliten, das ein Entkommen unmöglich macht.Während die eID dieser Tage unter Verwendung so hanebüchener Begründungen wie »Jugendschutz« oder zur »Eindämmung der Migrationskrise« global synchronisiert ausgerollt wird und Vietnam und Thailand zusammen bereits 89 Millionen Bankkonten von Kunden ohne biometrische ID gekündigt haben – siehe mein Text »Gefährliche Sicherheit« – schießen Unternehmen wie Space X (Starlink/Starshield) oder WISeKey/WISeSat für den militärisch-finanziellen Komplex bis 2030 zwischen 57.000 und 110.000 Satelliten ins All. Je nach Zählweise, Bauart und Flughöhe – siehe dazu mein Text »Orbitale Offensive«.Diese um den Planet Erde kreisende Hülle von Flugkörpern wird nicht primär für schnelles Internet sorgen, auch wenn Elon Musk genau das gerne werbewirksam in den Vordergrund stellt, es sind Überwachungs- und Angriffsinstrumente, deren Echtzeitkonnektivität für eine »umfassende IoT-Abdeckung auf der Erde« sorgen werden – indem sie jedes Gerät und jeden Sensor ansteuern, der internetfähig ist. Also praktisch alles....https://apolut.net/orbitale-offensive-addendum-von-tom-oliver-regenauer/ Hosted on Acast. See acast.com/privacy for more information.

Send us a textEpisode 352: In this episode, host Jamie Irvine interviews Randy King, National Sales Manager at MGM Brakes, who shares insights from his 47 years in the heavy-duty parts industry. The episode explores the differences between MGM's brake actuator models and their vocational applications, highlighting innovations like the dual thread release bolt and external breather tube technology that enhance performance and durability in tight, debris-prone environments. Randy also discusses the growing adoption of air disc brakes, particularly in transit fleets, due to improved stopping distances and reduced maintenance costs. A key focus is MGM's E-Stroke electronic brake monitoring system, which provides real-time diagnostics to detect issues like overstroke, dragging brakes, and sensor faults, helping fleets reduce downtime, prevent component damage, and improve safety. Links·         MGMBrakes.com Sponsors of this Episode The Hub Corp: Introducing the new standard in wheel-end protection: The Hub Corp's revolutionary XTRACTOR™. The only line of heavy-duty hub caps with a built-in 3-Stage Magnetic Oil Filter that safeguards critical axle components under extreme loads for longer. And with the patent-pending HexThread™ cartridge, the XTRACTOR makes hub oil servicing and inspections faster, easier, and cleaner. The Hub Corp: Challenge The Standard. Visit TheHubCorp.com to learn more and join the waitlist.   Fullbay: Fullbay is built for the heavy-duty world, giving your operation the tools to keep your fleet or independent repair shop running. Features like streamlined scheduling, real-time inventory tracking, technician efficiency insights, and detailed reports are how Fullbay helps shops reduce downtime and keep your vehicles on the road where they belong. Check out Fullbay.com/power to maximize your shop's productivity.GenAlpha: Equip360 by GenAlpha helps manufacturers and distributors grow their parts sales and make life easier for their customers. With real-time insights into inventory, pricing, and order tracking, it keeps customers coming back. Plus, it saves time by automating routine tasks and making repeat purchases simple. Explore Equip360 at GenAlpha.com.Disclaimer: This content and description may contain affiliate links, which means that if you click on one of the product links, The Heavy Duty Parts Report may receive a commission. Follow the podcast to never miss an episode. If you'd like to work with Jamie Irvine directly, you can schedule a meeting with him today.

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: Sanofi lowers prices, oral pill for T1D prevention studied, updates from Medtronic, Tandem, and Sequel Med Tech, falsely lower A1Cs (and why that happens), Biolinq gets FDA okay for micro-needle CGM and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX French drugmaker Sanofi says it would offer a month's supply of any of its insulin products for $35 to all patients in the U.S. with a valid prescription, regardless of insurance status. The program, originally meant for uninsured diabetes patients, would now include those with commercial insurance or Medicare, the drugmaker said. Patients will be able to purchase any combination, type, and quantity of Sanofi insulins with a valid prescription for the fixed monthly price of $35, starting January 1. Lilly and Novo also have similar programs through which they offer insulin products for $35 a month for U.S. patients regardless of whether the patients have insurance. There is no law at work here – the only legislation that has changed the price of insulin came with the Inflation Reduction Act in 2022 with the Medicare cap. Helping lower the cost here, biosimilars hitting the market and the huge profitability for GLP-1 drugs for Novo and Lilly https://www.reuters.com/business/healthcare-pharmaceuticals/sanofi-offer-all-insulin-products-35-per-month-us-2025-09-26/ XX A pill typically prescribed for rheumatoid arthritis and alopecia might help slow the progression of type 1 diabetes, a new study says. Baricitinib (bare-uh-SIT-nib) safely preserved the body's own insulin production in people newly diagnosed with type 1 diabetes.. and their diabetes started progressing once they stopped taking baricitinib, results show. They produced less insulin and had less stable blood sugar levels.   Baricitinib works by quelling signals in the body that spur on the immune system, and is already approved for treating autoimmune conditions such as rheumatoid arthritis, ulcerative colitis and alopecia, researchers said.   “Among the promising agents shown to preserve beta cell function in type 1 diabetes, baricitinib stands out because it can be taken orally, is well tolerated, including by young children, and is clearly efficacious,” Waibel said. “We are hopeful that larger phase III trials with baricitinib are going to commence soon, in people with recently diagnosed type 1 diabetes as well as in earlier stages to delay insulin dependence,” she added. “If these trials are successful, the drug could be approved for type 1 diabetes treatment within five years.”   Findings presented at medical meetings should be considered preliminary until published in a peer-reviewed journal.   https://www.usnews.com/news/health-news/articles/2025-09-23/pill-effective-in-slowing-type-1-diabetes-progression XX An existing transplant drug has shown promise in slowing the progression of type 1 diabetes in newly diagnosed young people, potentially paving the way for the first therapy that modifies the disease after diagnosis. The Drug, called ATG, is currently used together with other medicines to prevent and treat the body from rejecting a kidney transplant. It can also be used to treat rejection following transplantation of other organs, such as hearts, gastrointestinal organs, or lungs. The researchers studied 117 people aged five to 25, who'd been diagnosed with type 1 diabetes within the past three to nine weeks. The participants were from 14 centers across eight European countries and were randomized to be given different doses of ATG (0.1, 0.5, 1.5, or 2.5 mg/kg) or a placebo. ATG was given as a two-day intravenous (IV) infusion. The main goal was to see how well the pancreas could still make insulin after 12 months, measured by C-peptide levels during a special meal test. C-peptide is released into the blood along with insulin by the pancreas.   The findings are promising, showing that ATG, even at a relatively low dose, can slow the loss of insulin-producing cells in young people newly diagnosed with type 1 diabetes. The lower dose also caused fewer side effects, making it a more practical option. https://newatlas.com/disease/antithymocyte-globulin-newly-diagnosed-type-1-diabetes/     XX The FDA has delayed its feedback on Lexicon Pharmaceuticals' application to bring Zynquista (sotagliflozin) to people with type 1 diabetes. The agency had planned to respond this month but will now wait until the fourth quarter after reviewing new data from ongoing studies. Zynquista, an oral drug meant to be used with insulin, has already been approved for heart failure (marketed as Inpefa). But in type 1 diabetes, it faces safety concerns: last year an FDA advisory committee voted 11–3 that its benefits don't outweigh the increased risk of diabetic ketoacidosis (DKA). The FDA later issued a complete response letter rejecting the drug. Lexicon is still pushing forward, hoping its additional submissions will strengthen Zynquista's case for type 1 diabetes approval. https://www.biospace.com/fda/after-fda-rejection-lexicons-type-1-diabetes-drug-hit-with-another-regulatory-delay     XX A common but often undiagnosed genetic condition may be causing delays in type 2 diabetes diagnoses and increasing the risk of serious complications for thousands of Black and South Asian men in the UK—and potentially millions worldwide. A new study found around one in seven Black and one in 63 South Asian men in the UK carry a genetic variant known as G6PD deficiency. Men with G6PD deficiency are, on average, diagnosed with type 2 diabetes four years later than those without the gene variant. But despite this, fewer than one in 50 have been diagnosed with the condition.   G6PD deficiency does not cause diabetes, but it makes the widely used HbA1c blood test—which diagnoses and monitors diabetes—appear artificially low. This can mislead doctors and patients, resulting in delayed diabetes diagnosis and treatment.   The study found men with G6PD deficiency are at a 37% higher risk of developing diabetes-related microvascular complications, such as eye, kidney, and nerve damage, compared to other men with diabetes.   "This study highlights important evidence that must be used to tackle these health inequalities and improve outcomes for Black communities. Preventative measures are now needed to ensure that Black people, especially men, are not underdiagnosed or diagnosed too late." https://medicalxpress.com/news/2025-09-hidden-genetic-delay-diabetes-diagnosis.html XX Novo Nordisk today announced the resubmission of its Biologics License Application (BLA) to the US Food and Drug Administration (FDA) for Awiqli® (insulin icodec) injection, a once-weekly basal insulin treatment for adults living with type 2 diabetes. If approved, Awiqli® would become the first once-weekly basal insulin available in the United States, providing an alternative to daily basal insulin injections for adults living with type 2 diabetes.   The resubmission is based on results from the ONWARDS type 2 diabetes phase 3a program for once-weekly Awiqli® which is comprised of five randomized, active-controlled, treat-to-target clinical trials in approximately 4,000 adults with type 2 diabetes. The clinical program evaluated Awiqli® vs. daily basal insulin and the primary endpoint in these trials was change in A1C from baseline.1-5 Awiqli® is approved in the EU, along with 12 additional countries. In addition, regulatory filings have been completed in several other countries, with further regulatory decisions expected in 2025. XX Interesting news from Sequel Med Tech – they've signed an agreement with Arecor to pair the twiist pump with AT278 an ultra-concentrated (500U/mL), ultra-rapid insulin in development. They also have a deal with Medtronic to develop insulin for new pumps. This insulin isn't yet approved, it's 5 times stronger than standard fast acting  it's hoped that a clinical study will begin next year. Arecor says its insulin could potentially be the only option capable of enabling and catalyzing the next generation of longer-wear and miniaturized automated insulin delivery systems.   https://www.drugdeliverybusiness.com/sequel-arecor-develop-rapid-insulin-twiist/ XX Tandem Diabetes Care announes its t:slim X2™ insulin pump with Control-IQ+ automated insulin delivery (AID) technology is now cleared for use with Eli Lilly and Company's Lyumjev® (insulin lispro-aabc injection) ultra-rapid acting insulin in the United States (U.S.).   – The t:slim X2 insulin pump with Control-IQ+ technology is now cleared for use with Lyumjev for people with type 1 diabetes ages 2 and above and all adults with type 2 diabetes. The companies are continuing to work toward securing Lyumjev compatibility for the Tandem Mobi pump. https://hitconsultant.net/2025/09/29/tandem-diabetes-cares-tslim-x2-pump-cleared-for-use-with-lillys-ultra-rapid-lyumjev-insulin/ XX You can now place your order for the MiniMed™ 780G system with the Instinct sensor, made by Abbott. And if you are already a MiniMed 780G user, you can place an upgrade order today. ​This is a 15 day wear sensor, with no transmitter or overtape required. It looks the same at other Abbot sensors such as the Libre but is proprietary to Medtronic. Shipments are scheduled to start in November.   ​ https://www.drugdeliverybusiness.com/medtronic-launches-minimed-780g-instinct-abbott/   XX The global type 1 diabetes (T1D) burden continues to increase rapidly driven by rising cases, ageing populations, improved diagnosis and falling death rates. ,   The study estimates that T1D will affect 9.5 million people globally in 2025 (up by 13% since 2021), and this number is predicted to rise to 14.7 million in 2040. However, due to lack of diagnosis and challenges in collecting sufficient data, the actual number of individuals living with T1D is likely much higher, researchers say.   In fact, they estimate that there are an additional 4.1 million 'missing people' who would have been alive in 2025 if they hadn't died prematurely from poor T1D care, including an estimated 669,000 who were not diagnosed. This is particularly true in India, where an estimated 159,000 people thought to have died from missed diagnoses. The study predicts that 513,000 new cases of T1D will be diagnosed worldwide in 2025, of which 43% (222,000) will be people younger than 20 years old. Finland is projected to have the highest incidence of T1D in children aged 0-14 years in 2025 at around 64 cases per 100,000. The substantial increases in T1D forecasts between 2025 and 2040 underscore the urgent need for action. As co-author Renza Scibilia from Breakthrough T1D explains, "Early diagnosis, access to insulin and diabetes supplies, and proper healthcare can bring enormous benefits, with the potential to save millions of lives in the coming decades by ensuring universal access to insulin and improving the rate of diagnosis in all countries."   The authors note some important limitations to their estimates, including that while the analysis uses the best available data, predictions are constrained by the lack of accurate data in most countries-highlighting the urgent need for increased surveillance and research. They also note that data on misdiagnosis and adult populations remain limited, and the analysis assumes constant age-specific incidence and mortality over time. Furthermore, incidence data from the COVID-19 period were excluded from part of the modelling to avoid bias. Future updates are expected to improve as new data become available and applied. https://www.news-medical.net/news/20250919/New-study-warns-of-millions-of-undiagnosed-and-missing-people-with-type-1-diabetes.aspx XX A new study has found that semaglutide — the active ingredient found in some GLP-1 medications prescribed for diabetes and to aid weight loss — may help protect the eyes from diabetic retinopathy. Researchers estimate that as much as 40% of all people with diabetes also have diabetic retinopathy — a potentially blinding eye condition caused by blood vessel damage in the eye's retina. There is currently no cure for diabetic retinopathy. The condition is often managed through injections of anti-VEGF medications into the eye, surgery, and blood sugar monitoring and control. For this lab-based study, researchers used samples of human retinal endothelial cells that were treated with different concentrations of semaglutide. The cells were then placed in a solution with both a high glucose level and high level of oxidative stress — where there is an imbalance of antioxidants and free radicals — for 24 hours.   Past studies show that oxidative stress plays a role in the formation of diabetic retinopathy.   At the study's conclusion, researchers found that the retinal cells treated with semaglutide were twice as likely to survive than cells that were untreated. Additionally, the treated cells were found to have larger stores of energy.   Scientists also found that three markers of diabetic retinopathy were decreased in the semaglutide-treated retinal cells. First, the levels of apoptosis — a form of cell death — decreased from about 50% in untreated cells to about 10% in semaglutide-treated cells. The production of the free radical mitochondrial superoxide decreased from about 90% to about 10% in the treated retinal cells.   Researchers also found the amount of advanced glycation end-products — harmful compounds that can collect in people with diabetes and are known to cause oxidative stress — also decreased substantially.   Lastly, scientists reported that the genes involved in the production of antioxidants were more active in the semaglutide-treated cells when compared to untreated cells. Researchers believe this is a sign that semaglutide may help repair damage to the retinal cells.   “Our study did not find that these drugs harmed the retinal cells in any way — instead, it suggests that GLP1-receptor agonists protect against diabetic retinopathy, particularly in the early stages,” Ioanna Anastasiou, PhD, molecular biologist and postdoctoral researcher at the National and Kapodistrian University in Greece, and lead author of this study, said in a press release.   “Excitingly, these drugs may be able to repair damage that has already been done and so improve sight. Clinical trials are now needed to confirm these protective effects in patients and explore whether GLP-1 receptor agonists can slow, or even halt, the progression of this vision-robbing condition.” https://www.medicalnewstoday.com/articles/ozempic-semaglutide-may-help-protect-against-diabetes-related-blindness-retinopathy   XX Biolinq has received De Novo Classification from the U.S. Food and Drug Administration for its lead product, Biolinq Shine, a patch on the forearm that provides real-time glucose feedback through a primary color-coded LED display, visible with or without a phone. This one is tricky – it's called a needle free CGM but it also says it uses micro needles. By the way, De Novo isn't exactly the same as what we think of for FDA approval for medical devices. It's not as rigorous but it's a streamlined route for novel, low to moderate risk devices with no existing equivalent. We'll see how this one turns out. https://www.hmenews.com/article/biolinq-s-multi-function-biosensor-receives-fda-de-novo-classification

#newproducts JP's Product Pick of the Week 9/30/25 Simple Soil Moisture Sensor - For micro:bit, and more https://www.adafruit.com/product/6362 Visit the Adafruit shop online - http://www.adafruit.com ----------------------------------------- LIVE CHAT IS HERE! http://adafru.it/discord Subscribe to Adafruit on YouTube: http://adafru.it/subscribe New tutorials on the Adafruit Learning System: http://learn.adafruit.com/ -----------------------------------------

Spacecraft carry all kinds of sensors, but rarely the one humans rely on most: video. Despite offering the richest insight per watt, gram, and dollar, cameras have been largely absent from orbit.That's what TRL11 is out to change. The company is building radiation-tolerant optics, edge computers that process and compress video in real time, and ground software that turns footage into operational awareness. On this episode of Valley of Depth, I'm joined by Nicolaas Verheem, founder and CEO of TRL11. Nicolaas shares how his journey from pioneering wireless video at Teradek, work that won both technical Academy and Emmy Awards, led him to ask why space was still flying blind. We trace TRL11's path from early in-orbit demos to commercial traction with operators and defense, and dig into how edge intelligence and video awareness could transform the space economy. We also discuss:• Why video is the “missing sensor” in space• Lessons from TRL11's first orbital missionsThe three core use cases: health monitoring, mission awareness, and mission enablement• How software, not hardware, creates a lasting moat in space video• The long-term vision of human-like awareness in space…and more. • Chapters •01:03 – Nicol and Starwars and Startrek03:10 – Nicol winning an Academy Award and an Emmy04:14 – Nicol at Teradek05:13 – How Teradek inspired Nicol's current company TRL1106:30 – How video applies to the space industry09:41 – Why do we need video and what problem does it solve?12:56 – A ring camera for space17:06 – The story behind the company name19:32 – TRL11's current product offerings21:43 – Showing the operator what matters on screen24:53 – How do you build a space camera?26:45 – What TRL11 has learned in their early orbit tests29:06 – TRL11's primary first customers32:25 – Making the case for investors36:45 – Should every spacecraft have video onboard?38:03 – The importance of video for inspiration40:03 – Misunderstandings when it comes to video from partners, investors, and customers41:10 – Lessons Nicol learned building a company in the space industry42:42 – Fundraising at TRL1144:26 – Legacy and product evolution • Show notes •TRL11's website — https://www.trl11.com/Mo's socials — https://twitter.com/itsmoislamPayload's socials — https://twitter.com/payloadspace / https://www.linkedin.com/company/payloadspaceIgnition's socials — https://twitter.com/ignitionnuclear /  https://www.linkedin.com/company/ignition-nuclear/Tectonic's socials — https://twitter.com/tectonicdefense / https://www.linkedin.com/company/tectonicdefense/Valley of Depth archive — Listen: https://pod.payloadspace.com/ • About us •Valley of Depth is a podcast about the technologies that matter — and the people building them. Brought to you by Arkaea Media, the team behind Payload (space), Ignition (nuclear energy), and Tectonic (defense tech), this show goes beyond headlines and hype. We talk to founders, investors, government officials, and military leaders shaping the future of national security and deep tech. From breakthrough science to strategic policy, we dive into the high-stakes decisions behind the world's hardest technologies. Payload: www.payloadspace.com Ignition: www.ignition-news.comTectonic: www.tectonicdefense.com

A Japanese research team has unraveled the Venus flytrap's detailed mechanism to detect insects using its touch sensor.

The boys talk about the reasons it pays to buy a GOOD catalytic converter over the cheaper available versions. Cat installation problems, seasoning & efficiency all get some air time, then Ray details what he needs to do in order to mount a space age temperature sending unit. What to do with the stuff taken out of a storage garage and a caller's Rt.66 road trip fill up the rest of the hour this week.    Check our social media feed to see the pictures; on Instagram: @real_motormouthradio  and on You Tube: https://youtu.be/JIXUCo844II

Today, we are introducing the next generation of a tried-and-tested product: the F135 high-temperature inductive sensor, designed for the toughest environments, including ovens and autoclaves. Building on the success of its predecessor, the F35—which reliably handled temperatures up to 250 °C—the F135 delivers the same high-temperature performance with enhanced features that make installation, operation, and maintenance easier than ever. See omnystudio.com/listener for privacy information.

Welcome to Paranormal Spectrum, where we illuminate the enigmatic corners of the supernatural world. I'm your host, Barnaby Jones, and today we have a very special guest joining us:Johnny is a premier gear scientist, investigator, inventor, and media personality. He has worked with top tier personalities and teams across the U.S and continues to advance paranormal investigating through science based technology.Websitehttp://www.vortexparanormal.com/Facebookhttps://www.facebook.com/johnny.vortex.ParanormalYoutubehttps://www.youtube.com/@VortexParanormalMinnesotaClick that play button, and let's unravel the mysteries of the UNTOLD! Remember to like, share, and subscribe to our channel to stay updated on all the latest discoveries and adventures. See you there!Join Barnaby Jones on the Paranormal Spectrum every Thursday on the Untold Radio Network Live at 12pm Central – 10am Pacific and 1pm Eastern. Come and Join the live discussion next week. Please subscribe.We have twelve different Professional Podcasts on all the things you like. New favorite shows drop each day only on the UNTOLD RADIO NETWORK.To find out more about Barnaby Jones and his team, (Cryptids, Anomalies, and the Paranormal Society) visit their website www.WisconsinCAPS.comMake sure you share and Subscribe to the CAPS YouTube Channel as wellhttps://www.youtube.com/channel/UCs7ifB9Ur7x2C3VqTzVmjNQ

WEED-IT continues to refine its precision spraying technology with updates to its user interface and mapping capabilities. The updates were highlighted at Ag in Motion, where Thijs Van Harten of WEED-IT shared what’s new for Canadian growers using the spot-spray system. A major update is the new dash display, which features a streamlined interface and... Read More

This episode is part two of our conversation with Dr. Mark Trotter. In our conversation, Dr. Trotter provides as Australian Perspective of Technology in Agriculture. Through a great conversation, he brings his perspective of ag from Central Queensland University where he conducts research and works with producers to implement technology to improve efficiency within livestock [ Read More ]

As robots increasingly enter human spaces, robotics companies will need to think about safety differently than they did when robots were largely siloed from their human counterparts. Sonair thinks its sensors can help robotics companies reach their safety goals — with a solution that is both better and cheaper than popular LIDAR technology. Also, When most kids rebel against their families, they might become a ski bum, join a band, or go to art school. Shen Ming Lee decided to start a company. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Could your CO2 sensor be putting patients at risk? This eye-opening Rapid Response to Questions from our Readers episode explores a serious patient safety concern that every anesthesia professional needs to understand.We dive into two troubling cases where patients under general anesthesia developed respiratory acidosis despite normal-appearing monitoring parameters. The culprit? A semi-quantitative CO2 sensor being used in an operating room setting where it was never designed to function safely. Through detailed case analysis, we uncover how the Nihon Kohden cap-ONE TG920P CO2 analyzer—which operates on the assumption that inspired air contains zero CO2—failed to detect dangerous rebreathing when CO2 absorbers became exhausted.What makes this situation particularly concerning is that these semi-quantitative sensors display waveforms similar to their quantitative counterparts, creating a false sense of security. Dr. Amrutha Bindu Nagella shares her firsthand experience discovering the problem and her recommendations for preventing future incidents. We also hear Nihon Kohden's response, including their commitment to improving device labeling and safety warnings.This episode highlights a critical knowledge gap that exists when technology moves between different clinical environments without proper understanding of its limitations. Whether you're an anesthesiologist, CRNA, anesthesia technician, or hospital administrator making purchasing decisions, this information could prevent a potentially dangerous situation in your operating room. Subscribe to the Anesthesia Patient Safety Podcast for more essential safety updates that keep your patients protected during anesthesia care.For show notes & transcript, visit our episode page at apsf.org: https://www.apsf.org/podcast/272-behind-the-waveform-critical-safety-implications-of-co2-sensor-selection/© 2025, The Anesthesia Patient Safety Foundation

Dirty Word of the Day: Nastic movements. What to do in your landscape for September. FL state bird may be changed to the American Flamingo in 2026. Teresa answers your questions about amaryllis, summer squash infested with whiteflies, bromeliad & oak trees. Did you know its the law to have a working rain sensor on your irrigation system? Teresa gives advice on how to check them.

The panel wraps Apple's “Awe Dropping” coverage by debating iPhone 17 hardware: new vapor-chamber cooling, bigger batteries, a widened camera “deck,” triple 48MP sensors, square-format capture, brighter 3,000-nit displays, and up to 2TB storage. Chuck Joiner, David Ginsburg, Marty Jencius, Brian Flanigan-Arthurs, Jim Rea, Web Bixby, Eric Bolden, and Mark Fuccio contrast AirPods' translation “wow” with phones' incremental gains, weigh real-world benefits for creators, and critique Apple's moodier event production and revived case materials.  MacVoices is supported by Take Control Books: The Answers You Need Now, From Leading Experts. Start your library today. Show Notes: Chapters: [0:07] Vapor cooling, heat management, and battery talk [1:22] Battery size estimates and efficiency on Air vs Pro Max [3:27] The new camera “deck” and thermal/camera trade-offs [4:55] Triple 48MP sensors and square-format capture [7:07] “Speeds and feeds” vs real functionality debate [10:27] iOS features, innovation cycles, and upgrade cadence [12:45] Health features, incremental progress, and use cases [17:14] Hardware day vs software day expectations [20:40] Front camera uses for creators; landscape without rotation [24:07] Displays at 3,000 nits; storage to 2TB [25:37] Event production style: locations and lighting [27:14] Case materials return and real-world durability [30:56] Selfie stats and content-creation focus [35:56] Hats, humor, and closing plugs Links: Apple's ‘Awe Dropping' Event - Recording Guests: Web Bixby has been in the insurance business for 40 years and has been an Apple user for longer than that.You can catch up with him on Facebook, Twitter, and LinkedIn, but prefers Bluesky. Eric Bolden is into macOS, plants, sci-fi, food, and is a rural internet supporter. You can connect with him on Twitter, by email at embolden@mac.com, on Mastodon at @eabolden@techhub.social, on his blog, Trending At Work, and as co-host on The Vision ProFiles podcast. Brian Flanigan-Arthurs is an educator with a passion for providing results-driven, innovative learning strategies for all students, but particularly those who are at-risk. He is also a tech enthusiast who has a particular affinity for Apple since he first used the Apple IIGS as a student. You can contact Brian on twitter as @brian8944. He also recently opened a Mastodon account at @brian8944@mastodon.cloud. Mark Fuccio is actively involved in high tech startup companies, both as a principle at piqsure.com, or as a marketing advisor through his consulting practice Tactics Sells High Tech, Inc. Mark was a proud investor in Microsoft from the mid-1990's selling in mid 2000, and hopes one day that MSFT will be again an attractive investment. You can contact Mark through Twitter, LinkedIn, or on Mastodon. David Ginsburg is the host of the weekly podcast In Touch With iOS where he discusses all things iOS, iPhone, iPad, Apple TV, Apple Watch, and related technologies. He is an IT professional supporting Mac, iOS and Windows users. Visit his YouTube channel at https://youtube.com/daveg65 and find and follow him on Twitter @daveg65 and on Mastodon at @daveg65@mastodon.cloud. Dr. Marty Jencius has been an Associate Professor of Counseling at Kent State University since 2000. He has over 120 publications in books, chapters, journal articles, and others, along with 200 podcasts related to counseling, counselor education, and faculty life. His technology interest led him to develop the counseling profession ‘firsts,' including listservs, a web-based peer-reviewed journal, The Journal of Technology in Counseling, teaching and conferencing in virtual worlds as the founder of Counselor Education in Second Life, and podcast founder/producer of CounselorAudioSource.net and ThePodTalk.net. Currently, he produces a podcast about counseling and life questions, the Circular Firing Squad, and digital video interviews with legacies capturing the history of the counseling field. This is also co-host of The Vision ProFiles podcast. Generally, Marty is chasing the newest tech trends, which explains his interest in A.I. for teaching, research, and productivity. Marty is an active presenter and past president of the NorthEast Ohio Apple Corp (NEOAC). Jim Rea built his own computer from scratch in 1975, started programming in 1977, and has been an independent Mac developer continuously since 1984. He is the founder of ProVUE Development, and the author of Panorama X, ProVUE's ultra fast RAM based database software for the macOS platform. He's been a speaker at MacTech, MacWorld Expo and other industry conferences. Follow Jim at provue.com and via @provuejim@techhub.social on Mastodon. Support:      Become a MacVoices Patron on Patreon      http://patreon.com/macvoices      Enjoy this episode? Make a one-time donation with PayPal Connect:      Web:      http://macvoices.com      Twitter:      http://www.twitter.com/chuckjoiner      http://www.twitter.com/macvoices      Mastodon:      https://mastodon.cloud/@chuckjoiner      Facebook:      http://www.facebook.com/chuck.joiner      MacVoices Page on Facebook:      http://www.facebook.com/macvoices/      MacVoices Group on Facebook:      http://www.facebook.com/groups/macvoice      LinkedIn:      https://www.linkedin.com/in/chuckjoiner/      Instagram:      https://www.instagram.com/chuckjoiner/ Subscribe:      Audio in iTunes      Video in iTunes      Subscribe manually via iTunes or any podcatcher:      Audio: http://www.macvoices.com/rss/macvoicesrss      Video: http://www.macvoices.com/rss/macvoicesvideorss

In dieser Folge von Apple Talk Live dreht sich (fast) alles um das neue iPhone-Line-up von Apple: iPhone 17, iPhone 17 Pro/Pro Max und das brandneue iPhone Air. Gemeinsam mit unserem Gast Christian Just, Ressortleiter bei Computer Bild, sprechen wir über seine Eindrücke direkt vom Apple Event in Cupertino. Was kann das iPhone Air wirklich? Wie unterscheidet sich das neue Pro Max mit 2TB-Speicher und Vapor Chamber-Kühlung vom normalen Pro? Und ist das Air trotz der dünnen Bauweise alltagstauglich? Außerdem nehmen wir verschiedene neue Hüllen unter die Lupe, inklusive Unboxing einer hochwertigen Lederhülle von Pack & Smooch. Natürlich wie immer: werbefrei, unterhaltsam und mit jeder Menge technischer Expertise – und Pizza.

00:00: ☀️ Bom dia Tech!00:27:

In episode 96, Theresa and Kathryn sit down with Rebecca Sensor, middle school choir director and president-elect of the Pennsylvania Music Educators Association. Rebecca shares how her choir program transformed its traditional spring concert into a fully student-driven “Pops Concert,” where students select, arrange, and even mash up popular songs that resonate with them. From brainstorming on day one of school to building ballots of potential repertoire, Rebecca describes how giving students a voice in the process leads to deeper engagement, ownership, and creativity.Throughout the conversation, Rebecca highlights the powerful impact of student choice—not only on concert performances, but also on students' confidence, collaboration, and lifelong music-making. She also discusses how this approach has shifted her own teaching philosophy, the challenges and joys of balancing student ideas with practical rehearsal needs, and the little strategies that make rehearsals more meaningful. This inspiring episode offers both big-picture insights and practical takeaways for music educators who want to empower their students and make concerts more personal and memorable.Connect with Rebecca and learn more: Facebook: Rebecca Cogan SensorTikTok: (the real) Rebecca SensorLearn more about Pass the Baton: Pass the Baton websiteJoin the Coffee ClubSupport Pass the Baton Amplify student voice with Exit Tickets for Self-Reflection

This starts a two-part series where we get an Australian Perspective of Technology in Agriculture with Dr. Mark Trotter. Dr. Trotter brings his perspective of ag from Central Queensland University where he conducts research and works with producers to implement technology to improve efficiency within livestock operations. Tune in to learn how Australians are using [ Read More ]

He probado un Netatmo para medir el CO2 de mi despacho durante tres semanas. Y he descubierto que trabajar con aire viciado (lo cual ocurre antes de lo que pensamos) reduce nuestro rendimiento cognitivo sin que lo notemos.Contacta con el autor:X: @jlacortBluesky: @lacortMail: lacort@xataka.comLoop Infinito es un podcast de Applesfera sobre Apple y su ecosistema, publicado de lunes a viernes a las 7.00 h (hora española peninsular). Presentado por Javier Lacort. Editado por Alberto de la Torre.

7.5" 800x480 Tri-Color eInk / ePaper - Bare Display (0:20) https://www.adafruit.com/product/6415 Adafruit 3.52" 340x180 Quad-Color eInk / ePaper - Bare Display (3:13) https://www.adafruit.com/product/6414 Adafruit BMP580 I2C or SPI Temperature and Pressure Sensor - STEMMA QT (6:18) https://www.adafruit.com/product/6411 Adafruit BMP585 Ported I2C / SPI Temperature and Pressure Sensor - STEMMA QT (8:26) https://www.adafruit.com/product/6413 Visit the Adafruit shop online - http://www.adafruit.com ----------------------------------------- New nEw NEWs New Products, News, and more: https://www.adafruit.com/newsletter #newnewnew Shop for all of the newest Adafruit products: http://adafru.it/new Visit the Adafruit shop online - http://www.adafruit.com Adafruit on Instagram: https://www.instagram.com/adafruit LIVE CHAT IS HERE! http://adafru.it/discord Subscribe to Adafruit on YouTube: http://adafru.it/subscribe New tutorials on the Adafruit Learning System: http://learn.adafruit.com/ -----------------------------------------

7.5" 800x480 Tri-Color eInk / ePaper - Bare Display (0:20) https://www.adafruit.com/product/6415 Adafruit 3.52" 340x180 Quad-Color eInk / ePaper - Bare Display (3:13) https://www.adafruit.com/product/6414 Adafruit BMP580 I2C or SPI Temperature and Pressure Sensor - STEMMA QT (6:18) https://www.adafruit.com/product/6411 Adafruit BMP585 Ported I2C / SPI Temperature and Pressure Sensor - STEMMA QT (8:26) https://www.adafruit.com/product/6413 Visit the Adafruit shop online - http://www.adafruit.com ----------------------------------------- New nEw NEWs New Products, News, and more: https://www.adafruit.com/newsletter #newnewnew Shop for all of the newest Adafruit products: http://adafru.it/new Visit the Adafruit shop online - http://www.adafruit.com Adafruit on Instagram: https://www.instagram.com/adafruit LIVE CHAT IS HERE! http://adafru.it/discord Subscribe to Adafruit on YouTube: http://adafru.it/subscribe New tutorials on the Adafruit Learning System: http://learn.adafruit.com/ -----------------------------------------

Raspberry Pi Touch Display 2 - 5" 720x1280 with Capacitive Touch - SC1975 (0:41) https://www.adafruit.com/product/6408?utm_source=youtube&utm_medium=videodescrip&utm_campaign=newproducts FeatherS3[D] ESP32-S3 by Unexpected Maker (1:39) https://www.adafruit.com/product/6399?utm_source=youtube&utm_medium=videodescrip&utm_campaign=newproducts ProS3[D] ESP32-S3 by Unexpected Maker (1:39) https://www.adafruit.com/product/6398?utm_source=youtube&utm_medium=videodescrip&utm_campaign=newproducts TinyS3[D] ESP32-S3 by Unexpected Maker (1:39) https://www.adafruit.com/product/6401?utm_source=youtube&utm_medium=videodescrip&utm_campaign=newproducts Snap-on Enclosure for Adafruit USB Type C CC Resistor Fixer (3:38) https://www.adafruit.com/product/6409?utm_source=youtube&utm_medium=videodescrip&utm_campaign=newproducts Slim Right Angle USB C to USB C Cable - 23mm (4:22) https://www.adafruit.com/product/6367?utm_source=youtube&utm_medium=videodescrip&utm_campaign=newproducts Slim Right Angle USB C to USB C Cable - 40mm (4:22) https://www.adafruit.com/product/6368?utm_source=youtube&utm_medium=videodescrip&utm_campaign=newproducts Slim Right Angle USB C to USB C Cable - 75mm (4:22) https://www.adafruit.com/product/6372?utm_source=youtube&utm_medium=videodescrip&utm_campaign=newproducts Slim Right Angle USB C to USB C Cable - 75mm - Opposite Plugs (4:22) https://www.adafruit.com/product/6369?utm_source=youtube&utm_medium=videodescrip&utm_campaign=newproducts Slim Right Angle USB C to USB C Cable - 100mm (4:22) https://www.adafruit.com/product/6370?utm_source=youtube&utm_medium=videodescrip&utm_campaign=newproducts Slim Right Angle USB C to USB C Cable - 150mm (4:22) https://www.adafruit.com/product/6371?utm_source=youtube&utm_medium=videodescrip&utm_campaign=newproducts Adafruit BMP581 I2C or SPI Temperature Humidity Pressure Sensor - STEMMA QT (7:05) https://www.adafruit.com/product/6407?utm_source=youtube&utm_medium=videodescrip&utm_campaign=newproducts ----------------------------------------- New nEw NEWs New Products, News, and more: https://www.adafruit.com/newsletter #newnewnew Shop for all of the newest Adafruit products: http://adafru.it/new Visit the Adafruit shop online - http://www.adafruit.com Adafruit on Instagram: https://www.instagram.com/adafruit LIVE CHAT IS HERE! http://adafru.it/discord Subscribe to Adafruit on YouTube: http://adafru.it/subscribe New tutorials on the Adafruit Learning System: http://learn.adafruit.com/ -----------------------------------------

Raspberry Pi Touch Display 2 - 5" 720x1280 with Capacitive Touch - SC1975 (0:41) https://www.adafruit.com/product/6408?utm_source=youtube&utm_medium=videodescrip&utm_campaign=newproducts FeatherS3[D] ESP32-S3 by Unexpected Maker (1:39) https://www.adafruit.com/product/6399?utm_source=youtube&utm_medium=videodescrip&utm_campaign=newproducts ProS3[D] ESP32-S3 by Unexpected Maker (1:39) https://www.adafruit.com/product/6398?utm_source=youtube&utm_medium=videodescrip&utm_campaign=newproducts TinyS3[D] ESP32-S3 by Unexpected Maker (1:39) https://www.adafruit.com/product/6401?utm_source=youtube&utm_medium=videodescrip&utm_campaign=newproducts Snap-on Enclosure for Adafruit USB Type C CC Resistor Fixer (3:38) https://www.adafruit.com/product/6409?utm_source=youtube&utm_medium=videodescrip&utm_campaign=newproducts Slim Right Angle USB C to USB C Cable - 23mm (4:22) https://www.adafruit.com/product/6367?utm_source=youtube&utm_medium=videodescrip&utm_campaign=newproducts Slim Right Angle USB C to USB C Cable - 40mm (4:22) https://www.adafruit.com/product/6368?utm_source=youtube&utm_medium=videodescrip&utm_campaign=newproducts Slim Right Angle USB C to USB C Cable - 75mm (4:22) https://www.adafruit.com/product/6372?utm_source=youtube&utm_medium=videodescrip&utm_campaign=newproducts Slim Right Angle USB C to USB C Cable - 75mm - Opposite Plugs (4:22) https://www.adafruit.com/product/6369?utm_source=youtube&utm_medium=videodescrip&utm_campaign=newproducts Slim Right Angle USB C to USB C Cable - 100mm (4:22) https://www.adafruit.com/product/6370?utm_source=youtube&utm_medium=videodescrip&utm_campaign=newproducts Slim Right Angle USB C to USB C Cable - 150mm (4:22) https://www.adafruit.com/product/6371?utm_source=youtube&utm_medium=videodescrip&utm_campaign=newproducts Adafruit BMP581 I2C or SPI Temperature Humidity Pressure Sensor - STEMMA QT (7:05) https://www.adafruit.com/product/6407?utm_source=youtube&utm_medium=videodescrip&utm_campaign=newproducts ----------------------------------------- New nEw NEWs New Products, News, and more: https://www.adafruit.com/newsletter #newnewnew Shop for all of the newest Adafruit products: http://adafru.it/new Visit the Adafruit shop online - http://www.adafruit.com Adafruit on Instagram: https://www.instagram.com/adafruit LIVE CHAT IS HERE! http://adafru.it/discord Subscribe to Adafruit on YouTube: http://adafru.it/subscribe New tutorials on the Adafruit Learning System: http://learn.adafruit.com/ -----------------------------------------

Today, we are introducing our latest advancement in inductive sensor technology: a new generation of IO-Link-enabled sensors featuring extended functionality and diagnostics, along with the next iteration of our tried-and-tested analog inductive sensors. See omnystudio.com/listener for privacy information.

 It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: cancer reserach may lead to T1D treatment, GLP-1 oral pill moves forward, Tandem pharmacy moves, Medtronic-Abbott sensor unveield, parents of kids with T1D see income drop, Mannkind submits Afrezza for pediatrics, diabetes scholarships and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX Cornell researchers have developed an implant system that can treat type 1 diabetes by supplying extra oxygen to densely packed insulin-secreting cells, without the need for immunosuppression. The system could also potentially provide long-term treatment for a range of chronic diseases. This lab has produced previous implantable devices that have proved effective in controlling blood sugar in diabetic mice, but they can only last so long. "It's the proof of concept. We really proved that oxygenation is important, and oxygenation will support high cell-density capsules," Tempelman said. "The capsules are immune protective and last for a long time without having some kind of fouling of the membrane. The body never likes it when you put a foreign substance in. So that's the engineering in the Ma Lab, to look for materials and coatings for the materials that are immune protective, but also don't invoke excess response from the body because of the material." The next step will be to implant the system in a pig model, and also test it with human stem cells. The researchers are interested in eventually trying to use the system for implanting different cell types in humans for long-term treatment of chronic diseases, according to Tempelman, who is CEO of Persista Bio Inc., a new startup she founded with Ma and Flanders that is licensing these technologies. https://medicalxpress.com/news/2025-08-implant-diabetes-oxygenating-insulin-cells.html XX Mayo Clinic cancer research may be big news for T1D. After identifying a sugar molecule that cancer cells use on their surfaces to hide from the immune system, the researchers have found the same molecule may eventually help in the treatment of type 1. Cancer cells use a variety of methods to evade immune response, including coating themselves in a sugar molecule known as sialic acid. The researchers found in a preclinical model of type 1 diabetes that it's possible to dress up beta cells with the same sugar molecule, enabling the immune system to tolerate the cells. The findings show that it's possible to engineer beta cells that do not prompt an immune response   In the preclinical models, the team found that the engineered cells were 90% effective in preventing the development of type 1 diabetes. The beta cells that are typically destroyed by the immune system in type 1 diabetes were preserved.     https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-researchers-find-sugar-coating-cells-can-protect-those-typically-destroyed-in-type-1-diabetes/ XX A daily pill may be as effective in lowering blood sugar and aiding weight loss in people with Type 2 diabetes as the popular injectable drugs Mounjaro and Ozempic, according to results of a clinical trial announced by Eli Lilly on Thursday morning.   The drug, orforglipron, is a GLP-1, a class of drugs that have become blockbusters because of their weight-loss effects. But the GLP-1s on the market now are expensive, must be kept refrigerated and must be injected. A pill that produces similar results has the potential to become far more widely used, though it is also expected to be expensive.   Lilly said it would seek approval from the Food and Drug Administration later this year to market orforglipron for obesity and early in 2026 for diabetes. https://www.nytimes.com/2025/04/17/health/pill-glp-1-eli-lilly.html XX Use of diabetes technology has dramatically increased and glycemic control has improved among people with type 1 diabetes (T1D) in the US over the past 15 years, but at the same time, overall achievement of an A1c level < 7% remains low and socioeconomic and racial disparities have widened. These findings came from an analysis of national electronic health records of nearly 200,000 children and adults with T1D by Michael Fang, PhD, of the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, and colleagues. The study was published online on August 11, 2025, in JAMA Network Open. Use of continuous glucose monitors (CGMs) increased substantially from 2009-2011 to 2021-2023, from less than 5% in both children and adults to more than 80% and over half, respectively. While A1c levels did drop over the 15 years, just 1 in 5 children and slightly over a quarter of adults achieved a level < 7%. The average A1c level stayed above 8%, with ethnic minorities and low-income patients seeing the smallest gains.       https://www.medscape.com/viewarticle/diabetes-tech-use-rise-a1c-reductions-still-lag-2025a1000lc9 XX Inflammation may predict how well people with diabetes respond to depression treatment, and the effects differ dramatically between type 1 and type 2 diabetes. Diabetes and depression often appear together. Indeed, depression is more than three times more prevalent in people with type 1 diabetes (T1D) and nearly twice as prevalent in people with type 2 diabetes (T2D). When they appear together, treatment for depression can vary widely. In a new study, researchers from the German Diabetes Center (DDZ), the Research Institute of the Diabetes Academy Mergentheim (FIDAM), and the German Center for Diabetes Research (DZD) investigated how inflammation in the body relates to improvement in depression symptoms in people with T1D and T2D. The researchers combined data from three previous German randomized clinical trials that aimed to reduce elevated depressive symptoms and diabetes distress in people with type 1 or type 2 diabetes. Diabetes distress is characterized by feelings of overwhelm, frustration, guilt and worry about diabetes management and its potential complications. A total of 332 participants with T1D and 189 with T2D who had completed both a baseline and 12-month follow-up examination were included in the present study. Measures included depression using the Center for Epidemiological Studies Depression scale (CES-D), blood tests for 76 inflammatory biomarkers, and symptoms broken down into cognitive-affective (e.g., feeling hopeless), somatic (e.g., poor sleep, fatigue), and anhedonia (loss of pleasure) clusters.   After adjusting for factors like age, body mass index (BMI), diabetes duration, cholesterol, and co-existing illnesses, the researchers found that in patients with T1D, higher baseline inflammation was linked to smaller improvements in depression. Inflammation seemed to be more connected to physical/somatic symptoms in T1D patients. In those with T2D, higher baseline inflammation was linked to greater improvements in depression. For these patients, the effect was strongest for cognitive-affective and anhedonia – so, emotional and motivational – symptoms.   The researchers weren't sure what caused the difference between T1D and T2D, but they suggest it might be due to the different forms of immune activation seen in each condition. That is, autoimmune processes in type 1 and metabolic inflammation in type 2. https://newatlas.com/health-wellbeing/inflammation-diabetes-depression-treatment/ XX Parents of children diagnosed with type 1 diabetes suffer an income drop in the years following the diagnosis. The impact is more pronounced in mothers, especially mothers of children diagnosed in preschool years. And these findings come from a European study.. not the US. Previous research has shown that parents of children with type 1 diabetes are at increased risk of stress-related symptoms and may need to reduce their working hours. "In our study, we observed reduced parental work-related incomes in the years following the child's type 1 diabetes diagnosis. The drop was larger in mothers than in fathers. Since mothers earned significantly less than fathers in absolute terms, even before the child fell ill, the relative drop in mothers was 6.6% the year following diagnosis compared to 1.5% in fathers. We further note the greatest impact on work-related incomes in mothers of children diagnosed at preschool age," says Beatrice Kennedy, physician at the Endocrine and Diabetes unit at Uppsala University Hospital and Associate Professor of Medical Epidemiology at Uppsala University, who led the study. This is a huge study, builds on data from national population and health registers and the Swedish Child Diabetes Register (Swediabkids). The study includes the parents of more than 13,000 children diagnosed with type 1 diabetes in Sweden in 1993−2014, as well as more than half a million parents in the general population who have children not diagnosed with diabetes.   The researchers observed that the maternal pension-qualifying incomes (a composite outcome including work-related income and societal benefits) initially increased after the child's diagnosis. This was attributable to mothers applying for the parental care allowance from the Swedish Social Insurance Agency. The parental care allowance was intended to compensate for disease-related loss of work-related income and contribute toward disease-specific costs.   When the research team investigated long-term effects in mothers, they found that the pension-qualifying incomes gradually decreased after eight years, and had not recovered by the end of follow-up − 17 years after the children were diagnosed. https://www.news-medical.net/news/20250811/Mothers-face-greater-financial-impact-following-childe28099s-type-1-diabetes-diagnosis.aspx XX The U.S. Department of Justice has reached a settlement with Metro Nashville Public Schools after allegations that the district violated the Americans with Disabilities Act.   The parents of a student at the Ross Early Learning Center requested that the school monitor their child's glucose monitor. Investigators found the school refused to do so, despite the child's Type 1 Diabetes diagnosis.   As part of the settlement, MNPS agreed to change its policies to allow the use of these devices, ensure trained staff can monitor them throughout the entire school day and at school activities, and improve communication with parents. https://www.wsmv.com/2025/08/12/metro-nashville-public-schools-settles-allegations-it-discriminated-against-students-with-diabetes/ XX Modular Medical has unveiled Pivot, its next-generation insulin patch pump technology aimed at simplifying diabetes care. The company announced its new pump for “almost-pumpers” at the Association of Diabetes Care & Education Specialists (“ADCES”) Conference in Phoenix, Arizona this weekend. It aims for Pivot to target adults with a user-friendly, affordable design.   Modular Medical's current pump, the MODD1, won FDA clearance nearly a year ago. It features new microfluidics technology to allow for the low-cost pumping of insulin. The system has a reservoir size of 300 units/3mL. Users can monitor the pump activity with their cell phone and do not require an external controller. The pump uses a provided, single-use, disposable battery.   The company announced recently that it validated its insulin pump cartridge line for human-use production in the U.S. Days later, it reported the first human use of the MODD1 pump.   Now, it has taken the next steps with the debut of a next-gen pump, set for FDA submission in October.   Modular Medical also gamifies diabetes care The company also said ADCES is the place where it will showcase the first playable level of its new Pivot pump gamified trainin module. Level Ex, a developer of medical games, develops the module.   Modular Medical said gamification offers a way to make medical training more effective and efficient while improving information retention. Given the complexity in pump uptake, the company hopes to provide an easy way to bring its technology to clinicians and patients.   The company expects to have training modules available at the same time as the pump's planned launch in 2026.   “Level One is free because diabetes mastery shouldn't come with a price tag,” Sam Glassenberg, CEO of Level Ex, said. “Modular Medical is breaking barriers too – bringing pump therapy to more people through smart, accessible design. Together, we intend to make diabetes management simpler and more inclusive.   “People learn best through play – and we believe they want to learn about insulin pumps the same way. In Level One, players aren't just mastering diabetes management through gameplay – they're asking to ‘play' with pumps: to explore how they work, understand their benefits, and build confidence before using them in real life. Our partnership with Modular Medical helps make that possible.” https://www.drugdeliverybusiness.com/modular-medical-unveils-next-gen-insulin-pump/ XX On Tuesday, 12 August 2025, Tandem Diabetes Care (NASDAQ:TNDM) presented at the Canaccord Genuity's 45th Annual Growth Conference, outlining strategic shifts and market focus. The company highlighted its plans for commercial transformation in the U.S. and expansion in international markets, alongside addressing competitive challenges and regulatory impacts. While optimistic about growth in Outside the U.S. (OUS) markets, Tandem is navigating a more competitive landscape domestically. We have entered into the pharmacy channel with Mobi only. And so as Mobi's been building up volume, we're getting experience and we're really learning and understanding what pharmacy offers to us. And the proof points have proved out the thesis I said earlier, which is it can really reduce that barrier for patients, is the out of pocket cost. And so we've decided to accelerate our strategy and where we were starting just with Mobi, we are now moving t slim supplies into the pharmacy channel, and that will kick into gear in the fourth quarter. So as people are looking at the cadence of sales for the remainder of the year with this reframing, many folks are seeing what looks like a a might be an outsized fourth quarter and and having trouble understanding those dynamics. We'll be adding the tSIM supplies to those contracts. We also have more coverage. We will have it in the coming weeks effective this year, so we will be increasing that 30% rate before the end of the year. And then, obviously, everyone's in the same cycle right now already negotiating and discussing their 2026 coverage. And so 30% is the floor.   We do expect to continue to grow that coverage in the coming years, and ultimately have a much broader access. Absolutely. It's an exciting technology that allows for us to have an infusion set that extends the wear time from three days to up to seven days. So we're able to use that as part of an independent infusion set, which would then be used with the t slim and with the mobi pump today. But we're also using that same technology as part of the site that's used for mobi when you use it with a tubeless cartridge. So next year, we will launch Mobi in a patch configuration.   It uses the same pump that's available today, but by using a modified cartridge, you're able to wear it as a patch pump. So one of the things we announced on the call is that we're using this extended wear technology as part of that site. So what it allows you to do is to change the portion that you wear in your skin separate from the timing of when you change the insulin cartridge. So it allows for that extended wear time, reduction of burden to the patient, which is especially important for higher volume insulin users as we expand into type two. So from here, we will launch the extended wear site next year along with we'll do a separate regulatory filing for the cartridge portion for Mobi that includes this extended wear technology as a predicate device. So that's another filing that we'll need to do, but we have the clearance today for the independent infusion set, but we'll file another five ten k for use of the extended wear technology as part of the tubeless Mobi feature. https://za.investing.com/news/transcripts/tandem-diabetes-at-canaccord-conference-strategic-shifts-and-market-focus-93CH-3834464 XX MannKind today announced a significant regulatory submission and a large financing agreement with Blackstone. The company submitted its lead inhaled insulin product for expanded FDA approval and secured $500 million in funding, it said.   First, the Danbury, Connecticut-based company announced that it submitted a supplemental Biologics License Application (sBLA) for Afrezza, its inhaled insulin product, in the pediatric population.   MannKind Director of Medical and Scientific Engagement Joanne Rinker, MS, RDN, BC-ADM, CDCES, LDN, FADCES, told Drug Delivery Business News at ADA 2025 that a submission was on the way for children and adolescents aged 4-17 years old. Further data shared at ADA found Afrezza both safe and effective in that age range.   Afrezza is a fast-acting insulin formulation delivered through an inhaler device. MannKind engineered the mechanical inhaler device to slowly bring powder into the lung. A small compartment opens for the insertion of the insulin cartridge, then the user closes it. The only other component is a mouthpiece for the sake of cleanliness. Then, the inhalation takes just two seconds. It requires no electronics or extra components.   The company expects a review acceptance decision early in the fourth quarter of 2025.   “The submission of our supplemental Biologics License Application (sBLA) for Afrezza in pediatric patients is a meaningful milestone for MannKind and people living with diabetes,” said Michael Castagna, CEO of MannKind Corporation.   Additional funding provides a significant boost for MannKind MannKind also announced a strategic financing agreement with funds managed by Blackstone worth up to $500 million. The financing provides MannKind with non-dilutive capital to advance its short- and long-term growth strategies.   This senior secured credit facility includes a $75 million initial term loan funded at closing. It then has a $125 million delayed draw term loan available for the next 24 months. Finally, it features an additional $300 million uncommitted delayed draw term loan available at the mutual consent of MannKind and Blackstone.   The facility bears interest at a calculated SOFR variable rate plus 4.75% and matures in August 2030.   “This strategic financing significantly increases our operating flexibility and provides us substantial access to non-dilutive capital on favorable terms, complementing our strong cash position,” said Castagna. “The funding will support the expansion of our commercial team in preparation for the anticipated launch of the pediatric indication for Afrezza, if approved, continued pipeline advancement, potential business development opportunities, and general corporate purposes. Partnering with the Blackstone team on this transaction positions us to accelerate our next phase of growth and innovation.” https://www.drugdeliverybusiness.com/mannkind-fda-submission-pediatrics-500m-blackstone/ XX   Medtronic MiniMed Abbott Instinct Sensor [Image from Medtronic Diabetes on LinkedIn] The Medtronic Diabetes business today took to social media to share an early preview of a new integrated Abbott sensor for its insulin delivery systems. Medtronic Diabetes — soon to be MiniMed after its planned separation from the medtech giant – said in the post that the new sensor specifically designed for its own systems is called “Instinct.”   “Get a sneak peek at what's coming next: the Instinct sensor,” the business unit's account wrote. “Made by Abbott, the Instinct sensor is designed exclusively for MiniMed systems. We'll share more details about the Instinct sensor when it's commercially available.”   The sensor, built on the Abbott FreeStyle Libre platform, reflects “the power of the partnership,” Abbott EVP, Diabetes Care, Chris Scoggins, told Drug Delivery Business News earlier this year.   Medtronic and Abbott — two of the largest diabetes tech companies in the world — announced a year ago that they entered into a global partnership pairing Abbott continuous glucose monitors (CGMs) with Medtronic insulin delivery systems.   The partnership aims to collaborate on a system based on Abbott's FreeStyle Libre CGMs with Medtronic's automated insulin delivery technology (the latest generation being the MiniMed 780G) and smart insulin pen systems, such as the InPen system.   Read more about Medtronic, Abbott and the rest of the diabetes tech industry in our free Diabetes Technology Special Report. Medtronic's systems previously used its own CGMs, such as the Guardian 4 and the Simplera platform, and the company intends to continue using those systems as part of a comprehensive CGM portfolio. Under the companies' agreement, the systems would be sold exclusively by Medtronic — including the Abbott CGM.   The companies brought the partnership a step further in April when Medtronic announced the submission of an interoperable pump with the Abbott sensor technology to the FDA. They plan to share more details following the expected FDA clearance, which remains pending.   Management also recently emphasized the multi-year nature of the partnership, meaning Medtronic could pair current and future pumps with other Abbott sensors in the future. That could hint at integration with the company's future dual glucose-ketone monitor, as a number of pump makers have already announced collaborations to pair their systems with the sensor once it hits the market. https://www.drugdeliverybusiness.com/medtronic-diabetes-previews-abbott-sensor-minimed/ XX Governor Glenn Youngkin joined Civica officials at the company's Petersburg manufacturing facility to announce a $3 million grant from the Commonwealth of Virginia to accelerate Civica's efforts to develop and produce affordable insulin for Americans living with diabetes.   CivicaRx Logo   "We are proud to partner with Civica in their mission to make essential medicines more accessible," said Governor Youngkin. "This investment reflects our belief in the power of public-private collaboration to improve lives and strengthen communities."   These funds will support the production of insulin aspart, a rapid-acting human insulin analog used to regulate blood sugar in adults and children with diabetes. Civica plans to produce both rapid- and long-acting insulins at its state-of-the-art manufacturing facility in Petersburg, Va., where the company now employs more than 200 skilled workers.1 Over 8 million people living with diabetes need rapid-acting and/or long-acting insulin.   The Governor also announced that he had officially proclaimed August 7 – 14 2025 'Life Sciences Week' demonstrating the Commonwealth's commitment to "accelerating the advancement of the life sciences through public-private partnerships, STEM education, workforce development, and sustained investment in research and development."   "We are grateful for the Commonwealth's support," said Ned McCoy, Civica's President and CEO. "This funding will help us move closer toward our goal of ensuring that no one has to choose between insulin and other basic needs."   Civica and Virginia officials were joined by Lynn Starr, Chief Global Advocacy Officer of Breakthrough T1D, the leading global type 1 diabetes research and advocacy organization.   "More than one million American adults live with type 1 diabetes, and many still, sadly, ration their insulin, due to the prohibitively high cost of this necessary medication," said Starr.  "Civica's work will help to make insulin more affordable for people across the country."   Breakthrough T1D is among more than two dozen organizations and philanthropists, along with the states of Virginia and California, that have partnered with Civica to support the development of affordable insulins.   Civica's insulin initiative aims to provide patients with predictable, transparent pricing — no more than $30 per vial or $55 for a box of five pens — regardless of insurance status.   About Civica Civica is a nonprofit pharmaceutical company established to address drug shortages. It was founded by a group of U.S. health systems and philanthropies who, after more than a decade of chronic shortages, recognized that the market was not self-correcting and that a different approach is required. Civica works to deliver a safe, stable, and affordable supply of essential medicines to U.S. patients.   Media Contact: Liz Power liz.power@civicarx.org +1 860 501 3849 https://cbs4indy.com/business/press-releases/cision/20250807NY46213/governor-glenn-youngkin-announces-3-million-grant-to-support-civicas-affordable-insulin-programs/ XX If you or someone you love is living with diabetes, you already know the fight isn't just medical—it's financial, too. Between daily supplies, doctor visits, and long-term care, the cost of managing type 1 or type 2 diabetes can be overwhelming. Add college or trade school into the equation, and suddenly staying healthy competes with building a future. That's where scholarships for students with diabetes—like Beyond Scholars and others listed here—step in.   Whether you're headed to a university, a two-year college, or a hands-on trade program, these opportunities were created to ease the load.   Scholarships for students with diabetes Beyond Scholars (from Beyond Type 1): $10,000 for recently graduated high school seniors with type 1 diabetes or type 2 diabetes entering college or trade school. This is one of the largest needs-based diabetes scholarships in the United States. This year, awardees will also receive 6 months of wellness coaching through Risely Health.   Applications open: July 25, 2025 Deadline: August 29, 2025 Winners announced: October 2025 https://beyondtype1.org/beyond-scholars-diabetes-scholarships-college-trade-school/ XX Nick Jonas and Kyle Rudolph are using their platforms for a good cause.   On Tuesday, Aug. 12, the singer and the former NFL tight end (via his professional fundraising platform Alltroo) announced they're teaming up to launch a rally featuring a fan-coveted prize: a custom 2025 Volkswagen ID. Buzz electric bus that the Jonas Brothers have brought along for their 20th anniversary tour.   “Ten years ago, we hit the road with a goal to change what it means to live with diabetes. Since then, Beyond Type 1 has grown into the world's largest digital diabetes community, offering the tools, education, and peer support needed to not only survive but thrive with diabetes,” Jonas, who co-founded Beyond Type 1 (a nonprofit that advocates for those living with diabetes), says in a statement.     “We've challenged stigma, built community, provided life-saving resources, and collectively driven global innovation toward prevention and cure. This milestone is a moment to rally even more support for our mission, and partnering with Alltroo helps us do that in a powerful, engaging way.”   Related Stories Nick Jonas on Managing His Diabetes: 'The Mental and Emotional Health Aspect Is Really Important' nick jonas Nick Jonas Says He Was Diagnosed with Diabetes After Joe Told Their Parents: 'Something's Really Wrong' Joe Jonas and Nick Jonas attend the amfAR Cannes Gala 30th edition at Hotel du Cap-Eden-Roc on May 23, 2024 For Rudolph, the campaign is about "celebrating Beyond Type 1's incredible work over the past decade, and standing behind their vision of a world where everyone with diabetes — or at risk of it — has access to the knowledge, care and support needed for early diagnosis and lifelong health."   While the rally is live on Alltroo.com, fans can also scan QR codes available at all 36 Jonas Brothers concert stops to enter for a chance to win the electric bus. (A winner will be selected on November 14, which is World Diabetes Day.)   Jonas, 32, has long been open about his Type 1 diabetes diagnosis at 13 years old. "I had this kind of wrench thrown into things when I was diagnosed and it took a while to figure out how to count carbs to properly dose for insulin and what things would affect me in different ways," he previously told PEOPLE.   "When I was first diagnosed, I was sitting in the hospital and was scared to death, honestly, while I was learning about how to manage this new thing I was dealing with," Jonas recalled. "It would have been amazing to have someone to look at at that time to say, oh, this is a person living with it and they're following their dreams. They're doing what they want to do with their lives and not letting it slow them down."           https://people.com/nick-jonas-kyle-rudolph-launch-fan-rally-diabetes-awareness-11788684

2.13" 212x104 Flexible Monochrome / 4-Gray eInk ePaper Display - ILI0373 Chipset (0:18) https://www.adafruit.com/product/4243?utm_source=youtube&utm_medium=videodescrip&utm_campaign=newproducts 5.83" 648x480 Monochrome Black / White eInk / ePaper - Bare Display - UC8179 Chipset (1:15) https://www.adafruit.com/product/6397?utm_source=youtube&utm_medium=videodescrip&utm_campaign=newproducts Snap-on Enclosure for Adafruit TPS61169 Breakout (2:58) https://www.adafruit.com/product/6402?utm_source=youtube&utm_medium=videodescrip&utm_campaign=newproducts Adafruit JST PH Remover / Puller for LiPoly / LiIon Batteries (3:41) https://www.adafruit.com/product/6391?utm_source=youtube&utm_medium=videodescrip&utm_campaign=newproducts Adafruit MLX90632 FIR Remote Thermal Temperature Sensor - Medical Grade STEMMA QT / Qwiic (4:35) https://www.adafruit.com/product/6403?utm_source=youtube&utm_medium=videodescrip&utm_campaign=newproducts

2.13" 212x104 Flexible Monochrome / 4-Gray eInk ePaper Display - ILI0373 Chipset (0:18) https://www.adafruit.com/product/4243?utm_source=youtube&utm_medium=videodescrip&utm_campaign=newproducts 5.83" 648x480 Monochrome Black / White eInk / ePaper - Bare Display - UC8179 Chipset (1:15) https://www.adafruit.com/product/6397?utm_source=youtube&utm_medium=videodescrip&utm_campaign=newproducts Snap-on Enclosure for Adafruit TPS61169 Breakout (2:58) https://www.adafruit.com/product/6402?utm_source=youtube&utm_medium=videodescrip&utm_campaign=newproducts Adafruit JST PH Remover / Puller for LiPoly / LiIon Batteries (3:41) https://www.adafruit.com/product/6391?utm_source=youtube&utm_medium=videodescrip&utm_campaign=newproducts Adafruit MLX90632 FIR Remote Thermal Temperature Sensor - Medical Grade STEMMA QT / Qwiic (4:35) https://www.adafruit.com/product/6403?utm_source=youtube&utm_medium=videodescrip&utm_campaign=newproducts

After ten years, the Sony RX1R III is finally here. We take a look at this long-awaited compact camera from Sony and evaluate its specs and position in the market. Did Sony do something exciting here, or is it outclassed by other competitors such as Fuji? Also, Lucas has been to the movies recently, and has big opinions about aspect ratios. If you enjoy the show and want to contribute to our hosting costs, we'd welcome your support on Patreon. You can check it out here: https://www.patreon.com/cameragearpodcast Want to send us a question or comment, or just learn more about the show? Check out our website at https://cameragearpodcast.com, or email us directly at cameragearpodcast@gmail.com. Notes: Reflex-Nikkor 2000mm f/11 Lens [mir.com] DPReview forum thread from someone who has the lens Canon 5200mm f/14 Tele-Monster [Canon Watch] Sony's “Sensor on a Stick”: Inside the Radical Camera Tech Behind the F1 Movie [YM Cinema] Camp Snap CS-8 [PetaPixel] Apple patent for 20-stop DR image sensor [YM Cinema] Apple patent for soft membrane aperture [YM Cinema] Apple patent for actively cooled camera sensor [YM Cinema] Project Indigo [Adobe]

In this episode of The Dairy Nutrition Blackbelt Podcast, Dr. Roni Yair from Afimilk shares how advanced algorithms are transforming dairy cattle feed efficiency through behavioral data of individual cows. He explains the science behind predictive models, cross-farm research, and how dairies can use this data for strategic culling and breeding decisions. Listen now on all major platforms!"The two major applications of our feed intake prediction system are culling and breeding—using feed efficiency and profitability to guide better decision-making on timing and selection."Meet the guest: Dr. Roni Yair holds a Ph.D. in Animal Sciences from The Hebrew University of Jerusalem and completed postdoctoral research at Michigan State University, focusing on ruminant nutrition and hepatic metabolism. Now an animal scientist at Afimilk, he leads research in feed efficiency and dairy cattle behavior analytics.Liked this one? Don't stop now — Here's what we think you'll love!What will you learn: (00:00) Highlight(01:27) Introduction(03:17) Predicting feed intake(05:07) Sensor behavior data(08:37) Cross-farm prediction(10:48) Culling and breeding(15:57) Next research directions(20:14) Closing thoughtsThe Dairy Nutrition Blackbelt Podcast is trusted and supported by the innovative companies:Afimilk* Adisseo* Kemin* Priority IAC- Virtus Nutrition- Zinpro

‘The idea is to stop people dying from heat, which is a preventable death.' Learn more at https://www.yaleclimateconnections.org/ 

This is The Digital Story Podcast 1,006, July 1, 2025. Today's theme is, "The Enduring 20-Megapixel Sensor." I'm Derrick Story. Opening Monologue Olympus released their first 20MP sensor back in 2016. Since then, their Live MOS or the stacked BSI Live MOS sensors have been inside their Micro Four Thirds cameras. And even though Panasonic has a 25 MP version, OM System has stuck with theirs. Today, you'll discover why. All of this and more on this week's TDS Photography Podcast. I hope you enjoy the show.

Seattle can be a dangerous place to ride your bike. On some roads, cars just get too close. And if you’re new to cycling here, how do you know which routes are safest? We talk with University of Washington PhD student Joe Breda, who's developed a handlebar sensor that's helping to map the region’s riskiest bike routes. We can only make Seattle Now because listeners support us. Tap here to make a gift and keep Seattle Now in your feed. Got questions about local news or story ideas to share? We want to hear from you! Email us at seattlenow@kuow.org, leave us a voicemail at (206) 616-6746 or leave us feedback online.See omnystudio.com/listener for privacy information.

This episode was such a fun mix of science, emotions, and hot tubs that could cook a turkey! We started with some thoughts on Western States, less than 3 weeks out from the race. Does embracing the stage also mean embracing social media posts telling you that you aren't being picked to perform well? Our argument channeling Tyrese Halliburton of the Indiana Pacers: the “noise” can be performance enhancing if you have fun with it!The main science topic was a WILD study on the hot tub improving hemoglobin levels, resting heart rate, and altitude performance. It's “wild” because the hot tub was set astonishingly high, with participants staying in for an astonishingly long time. I like my participants like I like my eggs: hard-boiled. We talk about what it means and why passive heat training might be the easiest advanced training intervention that goes beyond the basics.And this one was full of our favorite topics! Other topics: a training trip out to the Western States course, Kilian Jornet searching for a pacer, Cam Jones consuming 185 grams of carbs per hour on his way to winning Unbound Gravel, Jessie Diggins' amazing poem on fueling her body to take a hit, a study on ketones and altitude that found no benefits, using downhills to improve strength for flat running, and a genetic link between muscle stiffness and strains, plus a Q+A on the new OTQ standards getting faster for men (we don't like it), whether to GO FOR IT if going for it might not lead to your big goals, a hypothetical about gold medalist Kristian Blummenfelt at a mountain race, and heat and family planning.The episode finishes up with questions about alcohol and celebrity-flavored bathwater. It'll make sense soon. Maybe.We love you all! A unit for a unit,-David and MeganClick "Claim Reward" for free credit at The Feed here: thefeed.com/swap Order a Core 2 Sensor here before they sell out: https://thefeed.com/products/core-2-temperature-monitorBuy Janji's amazing gear: https://janji.com/ (code "SWAP")For weekly bonus podcasts, articles, and videos: patreon.com/swap

We gulped down some pungent juice before recording this amazing episode! The main topics were the two big pieces of news: Jim Walsmley won't be racing Western States, and Kilian Jornet is making training videos now. Jim is the GOAT and we gave him an 85% chance of winning just last week. He's the supermassive black hole at the center of the Western States galaxy. Without Jim at the start line, how does it change the race? Kilian is the GOAT too (yes, we have a GOAT herd), and he just released a training video! He abides by the "no secrets" approach, and we analyzed every frame of that video to try to find clues about whether he might be beatable. Answer: no. Bonus answer: Kilian is the best and it's fascinating that he started his own video series by talking about his heat training.And this one was full of great topics! Other topics: our magical coaching day at the US Mountain Championships, thoughts on training for mountain races, Unbreakable 2 cancellation, the wild triumph of Simon Yates, a new bicarb gel that could upend the bicarb market, the wild science of broccoli sprouts and a new juice supplement from Nomio, anti-histamines and athletic performance, why we're eating dark chocolate (it tastes good), lung training via breathing devices, the relationship between speed work and form in ultras, a hypothetical about Conner Mantz racing Leadville or Western States, an article in the New York Times on unethical mountaineering, training with a newborn, dealing with life transitions, fitting the Naked Belt, the cost of running, cheaper suphershoes, and an incredible poem on failing and flying.Everyone forgets that Icarus also flew. Also, if Icarus had broccoli sprouts and Kilian's training video, maybe he would have flown a bit longer.We love you all! HUZZAH! Click "Claim Reward" for free credit at The Feed here: thefeed.com/swap Order a Core 2 Sensor here before they sell out: https://thefeed.com/products/core-2-temperature-monitorBuy Janji's amazing gear: https://janji.com/ (code "SWAP")For weekly bonus podcasts, articles, and videos: patreon.com/swap